Xero Shares Crash Through $100 Barrier To New Low

Xero’s share price (ASX: XRO) breached a critical psychological threshold today, with shares plunging below A$100 for the first time in over a year as mounting concerns over its US expansion strategy collide with broader technology sector weakness.

Xero shares closed 5.15% lower at A$98.90 on Wednesday, having touched an intraday low of A$98.23 during the session. The sharp decline extends a brutal six-month period that has seen the stock shed 45% of its value, while the past month alone has delivered losses of 14.46%. The breakdown of the A$100 level represents a significant technical failure for a stock that traded above A$176 as recently as June 2025.

Wednesday’s sell-off mirrored weakness across global technology markets, with the tech-heavy Nasdaq 100 Index falling 2.12% overnight as geopolitical tensions escalated between the United States and Europe over Greenland. The spillover effect hit growth-oriented technology stocks particularly hard, with markets reassessing valuations amid rising uncertainty.

However, Xero’s troubles extend well beyond short-term market volatility. The company’s US$2.5 billion acquisition of American payments platform Melio in June 2025 has emerged as a pivotal moment that fundamentally altered market sentiment. To finance the deal, Xero conducted a A$1.85 billion institutional placement at A$176 per share, a 9.4% discount to the previous closing price. The market’s immediate response was unforgiving, with shares dropping 9% when trading resumed as concerns mounted over the substantial capital outlay and dilutive impact on existing shareholders.

The Melio acquisition was designed to accelerate Xero’s penetration of the lucrative North American market, where it faces entrenched competition from Intuit’s QuickBooks platform. Yet the strategic rationale has been overshadowed by execution concerns and emerging regulatory headwinds. In September 2025, RBC Capital downgraded Xero from “Outperform” to “Sector Perform,” slashing its price target from A$230 to A$187. The downgrade followed reports that JPMorgan was proposing data and access fees for fintech payments players operating in the United States, a development that could materially impact both Xero and Melio’s economics.

RBC Capital’s analysis painted a sobering picture, estimating that such banking fees could reduce Xero’s gross profit by up to 7% and EBITDA by as much as 27% in a worst-case scenario. The potential for compressed margins in what is already a highly competitive market has forced markets to reconsider the growth-at-any-cost thesis that previously underpinned Xero’s premium valuation.

Competitive dynamics in North America have also disappointed. In November 2025, Xero reported 21% revenue growth in its US/Canada segment, a figure that fell short of analyst expectations and raised questions about the company’s ability to gain meaningful share against Intuit’s dominant position. The underperformance suggested that breaking into the North American market would require more time and investment than initially anticipated, further pressuring near-term profitability metrics.

The convergence of these company-specific challenges with broader market volatility has put Xero shareholders in a difficult position. Geopolitical tensions, including potential US tariffs on European nations and trade policy uncertainty, have prompted markets to de-rate high-growth technology stocks trading on elevated multiples. For Xero, which historically commanded a premium valuation based on its strong market position in Australia and New Zealand and its US growth potential, the reassessment has been particularly painful.

The technical breakdown below A$100 carries psychological weight beyond the nominal price level. For many growth stocks, round numbers serve as important support and resistance zones where institutional trading algorithms and retail investor sentiment converge. The breach of this threshold could trigger additional selling pressure if the level cannot be quickly reclaimed, particularly as momentum-based strategies exit positions showing persistent weakness.

Looking ahead, Xero faces a delicate balancing act between defending its core Australasian market, where it maintains strong competitive positioning, and investing aggressively to capture share in North America without sacrificing profitability. The company’s next financial results will be scrutinized for evidence that the Melio integration is proceeding smoothly and that the combined entity can deliver synergies that justify the acquisition premium.